Express News | Matinas BioPharma Hldgs Q4 EPS $(0.26) Up From $(1.68) YoY

BenzingaMar 31 18:50 ET

Matinas BioPharma | 10-K: Annual report

SECMar 31 16:50 ET · Announcements

12 Health Care Stocks Moving In Thursday's Pre-Market Session

BenzingaFeb 26 07:05 ET

Why Marriott Vacations Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket

BenzingaFeb 26 04:38 ET

Invasive Fungal Infections Market to Witness Upsurge in Growth at a CAGR of 11.4% (in the US) During the Forecast Period (2025-2034) | DelveInsight

PR NewswireFeb 9 17:31 ET

Matinas BioPharma CFO Keith Kucinski Resigns; CEO Jerome Jabbour Appointed Interim CFO

BenzingaJan 23 17:08 ET